Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO June 15, 2017 Tissue Regenix Banks $52 Million and Pays $30 Million for Texas' July 20, 2017 With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial November 15, 2017
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial November 15, 2017
